Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
247 hedge funds and large institutions have $3.4B invested in Arena Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 82 increasing their positions, 74 reducing their positions, and 29 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 3 → 9 (+6)
118% more call options, than puts
Call options by funds: $44.6M | Put options by funds: $20.4M
103% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 29
79% more capital invested
Capital invested by funds: $1.9B → $3.4B (+$1.5B)
13% more funds holding
Funds holding: 218 → 247 (+29)
11% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 74
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alkeon Capital Management
New York
|
+$54.5M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$52.3M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$50.3M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$49.5M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$47.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$26.8M |
| 2 |
Holocene Advisors
New York
|
-$24.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$22.3M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$19.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
ARNA Hedge Fund Activity: Q2 2020 in Review
247 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2020, worth a combined $3.4B — up 79% from $1.9B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new ARNA positions and 29 closed out — a net gain of 30 holders — while 82 added to existing stakes and 74 trimmed.
The largest buyer was Alkeon Capital Management, adding an estimated $54.5M. The largest seller was PFM Health Sciences, cutting an estimated $26.8M.
- 247 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2020, up from 218 in Q1 2020.
- Funds reported $3.4B of Arena Pharmaceuticals Inc stock for Q2 2020, up 79% quarter-over-quarter.
- 59 funds opened new Arena Pharmaceuticals Inc positions in Q2 2020 and 29 closed out, a net change of +30 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q2 2020 was Alkeon Capital Management, an estimated $54.5M added.
- The largest Arena Pharmaceuticals Inc seller in Q2 2020 was PFM Health Sciences, an estimated $26.8M sold.
Based on aggregated 13F filings for Q2 2020.